Skip to main content

Cafepharma Today

August 22 2025 - Oral obesity candidates disappoint with Novo emerging as leader of the pack

Oral obesity candidates disappoint with Novo emerging as leader of the pack
Eli Lilly board, Novo Nordisk board 
More than 1,100 devices have received the FDA’s breakthrough designation
Medtech boards
CVS Caremark ordered to pay $290M in false claims suit
CVS Caremark board
Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass
Pharma/Biotech General Discussion board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act

Current News



Latest CP Wire Articles

Top 15 Pharmaceutical Companies for Salespeople in 2025
Top 20 Medical Device Companies for Salespeople in 2025
AbbVie announces a $195 million investment in US API manufacturing
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader [release]
Radella Pharmaceuticals’ peptide obesity drug shows improved cardiovascular markers and muscle-sparing weight loss in trial
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling [release]
Kedrion Biopharma Receives Orphan Drug Designation for COAGADEX® for Acquired Factor X Deficiency (aFXD) and Starts Clinical Trial to Evaluate Efficacy and Safety [release]
Creative Biolabs Conducts a Webinar on Tumoroid-on-a-Chip Model for Immunotherapy
Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?

Latest Pharmagather Articles